GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO)
India flag India · Delayed Price · Currency is INR
2,264.60
-18.15 (-0.80%)
Dec 24, 2024, 3:30 PM IST

NSE: GLAXO Company Description

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally.

The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia.

It also provides specialty medicines comprising NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease.

In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, which are antibiotics to treat bacterial infections; CALPOL for treatment of mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment and prevention of specific bacterial skin infections; BETNOVATE for skin conditions which require relief of inflammation; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin and dry skin associated with redness and itch.

Further, it develops products for infectious diseases, HIV, oncology, and immunology. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001.

GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals logo
Country India
Founded 1924
Industry Drug Manufacturers - General
Sector Healthcare
Employees 3,211
CEO Bhushan Akshikar

Contact Details

Address:
GSK House
Mumbai, Maharashtra 400030
India
Phone 91 22 2495 9595
Website india-pharma.gsk.com

Stock Details

Ticker Symbol GLAXO
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE159A01016
SIC Code 2834

Key Executives

Name Position
Bhushan Akshikar MD and Executive Director
Juby Chandy Whole-Time Director and Chief Financial Officer
Chinmay Sharma Executive Vice President of Human Resources
Aparajita Rajput Vice President of Technology
Ajay Avinash Nadkarni Vice President of Administration and Real Estate and Company Secretary
Amit G. Pandey Executive Vice President of Legal
Simrat Sohal Vice President of Ethics and Compliance
Ransom D'Souza Executive Vice President of Communications and Government Affairs
Sukanya Choudhary Executive Vice-President of Regulatory Affairs
Shourov Mukherjee Executive Vice-President of Adult Vaccines